Amylyx Pharmaceuticals, Inc. AMLX Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s earnings yield?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported earnings yield of -9.8% in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s earnings yield changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s earnings yield increased by 86.0% year-over-year, from -69.8% to -9.8%.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s earnings yield?
- Over 3 years (2022 to 2025), Amylyx Pharmaceuticals, Inc.'s earnings yield has grown at a 10.0% compound annual growth rate (CAGR), from -8.2% to -10.9%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.